Cognition Therapeutics, Inc. (CGTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -5.54M | -3.44M | -5.65M | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.46M | -4.16M | -3.7M | -2.71M | -10.18M | -4K | -5.36M | -2.99M | 101K | -2.05M | -910K |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | 43.89% | 59% | 17.52% | 6.24% | -36.35% | -53.63% | -64.65% | -62.26% | -167.8% | 46.43% | -103925% | 31.01% | 9.47% | -10183.17% | 99.8% | -488.68% | -287.05% | 121.04% | - | - |
| Net Income | -4.57M | -3.34M | -4.93M | -6.73M | -8.48M | -7.84M | -9.94M | -7.04M | -9.15M | -8.14M | -6.75M | -4.73M | -6.17M | -5.18M | -6.63M | -5.75M | -3.84M | -7.34M | -3.11M | -1.49M |
| Depreciation & Amortization | 68K | 61K | 61K | 61K | 45K | 71K | 70K | 67K | 58K | 66K | 65K | 61K | 60K | 60K | 60K | 59K | 56K | 23K | 23K | 24K |
| Stock-Based Compensation | 330K | 0 | 522K | 621K | 586K | 534K | 896K | 1.15M | 1.17M | 1.07M | 1.07M | 1.02M | 1.19M | 902K | 777K | 892K | 1M | 4.92M | 72K | 94K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -846K | 0 | -691K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.37M | 399K | 0 | 0 | 0 | 0 | 0 | 0 | 195K | 841K | 5K | 691K | 318K | 0 | 0 | 0 | 0 | 260K | 932K | -1K |
| Working Capital Changes | 0 | -554K | -1.3M | 429K | -2.03M | -1.15M | 2.12M | -170K | 483K | 1.55M | 1.45M | -56K | 1.9M | -5.96M | 5.78M | -556K | -207K | 2.24M | 33K | 463K |
| Change in Receivables | 0 | -8.02M | 4.38M | -1.51M | -2.09M | 683K | -270K | -2.24M | 420K | 357K | 755K | -784K | 2.06M | -1.14M | 1.23M | -501K | -528K | -1.09M | 1.39M | -237K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.43M | -456K | -2.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -7.57M | 8.41M | -5.44M | 614K | -75K | 0 | 0 | 1.73M | -377K | 0 | 672K | 1.24M | -75K | -5.01M | 4.78M | -693K | -171K | 2.44M | -698K | -533K |
| Cash from Investing | 0 | 9K | 0 | 0 | 0 | -1K | 0 | -3K | 0 | -30K | -58K | -18K | -41K | -10K | -23K | -4K | -134K | -27K | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | -1K | 0 | -3K | 0 | -30K | -58K | -18K | -41K | -10K | -23K | -4K | -134K | -27K | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -233K | 605K | 33.92M | 752K | 1.3M | 11.38M | 329K | -138K | 11.99M | 2.44M | -3K | 2.1M | -10K | 5.14M | 869K | -374K | -91K | 46.36M | -961K | -1.16M |
| Debt Issued (Net) | 0 | -74K | -41K | -120K | -118K | -195K | -185K | -181K | -178K | -179K | -215K | -210K | -207K | -205K | -401K | -396K | -394K | -268K | 0 | 0 |
| Equity Issued (Net) | 0 | 756K | 33.99M | 877K | 1.46M | 11.58M | 497K | 65K | 12.28M | 2.62M | 212K | 2.31M | 197K | 5.35M | 0 | 22K | 303K | 46.63M | 0 | -1.16M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -233K | -77K | -36K | -5K | -46K | 0 | 17K | -22K | -106K | 0 | 0 | 0 | 0 | 0 | 1.27M | 0 | 0 | 0 | -961K | 0 |
| Net Change in Cash | -5.78M | -2.82M | 28.27M | -4.87M | -8.58M | 3M | -6.52M | -6.14M | 4.75M | -3.05M | -4.22M | -1.62M | -2.75M | -5.05M | 839K | -5.74M | -3.21M | 46.41M | -2.99M | -2.07M |
| Free Cash Flow | -5.54M | -3.44M | -5.65M | -5.62M | -9.88M | -8.38M | -6.85M | -6M | -7.24M | -5.49M | -4.22M | -3.71M | -2.75M | -10.19M | -27K | -5.36M | -3.12M | 74K | -2.05M | -910K |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | 43.89% | 59% | 17.52% | 6.28% | -36.35% | -52.81% | -62.38% | -61.55% | -163.8% | 46.18% | -15525.93% | 30.72% | 12.04% | -13875.68% | 98.68% | -489.12% | -304.4% | 115.42% | - | - |
| FCF per Share | -0.06 | -0.04 | -0.07 | -0.09 | -0.16 | -0.18 | -0.17 | -0.15 | -0.21 | -0.18 | -0.14 | -0.13 | -0.09 | -0.35 | -0.00 | -0.24 | -0.14 | 0.00 | -0.10 | -0.04 |
| FCF Conversion (FCF/Net Income) | - | 1.03x | 1.15x | 0.84x | 1.16x | 1.07x | 0.69x | 0.85x | 0.79x | 0.67x | 0.62x | 0.78x | 0.44x | 1.97x | 0.00x | 0.93x | 0.78x | -0.01x | 0.66x | 0.61x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |